Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Director comp.

Milestone Pharmaceuticals Inc. (MIST) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/09/2023 4 Wills Robert James (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.
Txns: Granted 30,000 options to buy @ $3.86, valued at $115.8k
06/09/2023 4 TOMSICEK MICHAEL JOHN (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.
Txns: Granted 30,000 options to buy @ $3.86, valued at $115.8k
06/09/2023 4 Pasternak Richard C (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.
Txns: Granted 30,000 options to buy @ $3.86, valued at $115.8k
06/09/2023 4 Liebert Debra K. (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.
Txns: Granted 30,000 options to buy @ $3.86, valued at $115.8k
06/09/2023 4 Giles Lisa M. (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.
Txns: Granted 30,000 options to buy @ $3.86, valued at $115.8k
06/09/2023 4 Fischer Seth H. Z. (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.
Txns: Granted 30,000 options to buy @ $3.86, valued at $115.8k
03/24/2023 4 RTW INVESTMENTS, LP (10% Owner) has filed a Form 4 on Milestone Pharmaceuticals Inc.
Txns: Disposed of 1,059,000 shares @ $0
03/23/2023 4 Fischer Seth H. Z. (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.
Txns: Granted 42,000 options to buy @ $3.45, valued at $144.9k
03/23/2023 3 Fischer Seth H. Z. (Director) has filed a Form 3 on Milestone Pharmaceuticals Inc.
12/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/15/2022 4 Liebert Debra K. (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.
Txns: Acquired 127 shares @ $0
09/09/2022 4 RTW INVESTMENTS, LP (10% Owner) has filed a Form 4 on Milestone Pharmaceuticals Inc.
Txns: Bought 1,557,346 shares @ $8.71, valued at $13.6M
Sold 1,557,346 shares @ $8.71, valued at $13.6M
08/17/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
08/11/2022 4 Pasternak Richard C (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.
Txns: Granted 30,000 options to buy @ $6.07, valued at $182.1k
08/11/2022 4 TOMSICEK MICHAEL JOHN (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.
Txns: Granted 30,000 options to buy @ $6.07, valued at $182.1k
08/11/2022 4 Wills Robert James (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.
Txns: Granted 30,000 options to buy @ $6.07, valued at $182.1k
08/11/2022 4 Giles Lisa M. (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.
Txns: Granted 30,000 options to buy @ $6.07, valued at $182.1k
08/11/2022 4 Liebert Debra K. (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.
Txns: Granted 30,000 options to buy @ $6.07, valued at $182.1k
06/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/23/2022 4 Oliveto Joseph (President and CEO) has filed a Form 4 on Milestone Pharmaceuticals Inc.
Txns: Granted 500,000 options to buy @ $5.46, valued at $2.7M
03/23/2022 4 Hasija Amit (CFO & EVP of Corp. Development) has filed a Form 4 on Milestone Pharmaceuticals Inc.
Txns: Granted 175,000 options to buy @ $5.46, valued at $955.5k
03/23/2022 4 Muller Lorenz (Chief Commercial Officer) has filed a Form 4 on Milestone Pharmaceuticals Inc.
Txns: Granted 160,000 options to buy @ $5.46, valued at $873.6k
02/17/2022 4 Bharucha David (Chief Medical Officer) has filed a Form 4 on Milestone Pharmaceuticals Inc.
Txns: Granted 330,000 options to buy @ $6.47, valued at $2.1M
02/17/2022 3 Bharucha David (Chief Medical Officer) has filed a Form 3 on Milestone Pharmaceuticals Inc.
07/29/2021 4 TRUEX PAUL F (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.
Txns: Granted 30,000 options to buy @ $5.54, valued at $166.2k
07/29/2021 4 TOMSICEK MICHAEL JOHN (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.
Txns: Granted 30,000 options to buy @ $5.54, valued at $166.2k
07/29/2021 4 Pasternak Richard C (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.
Txns: Granted 30,000 options to buy @ $5.54, valued at $166.2k
07/29/2021 4 Liebert Debra K. (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.
Txns: Granted 30,000 options to buy @ $5.54, valued at $166.2k
07/29/2021 4 Giles Lisa M. (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.
Txns: Granted 30,000 options to buy @ $5.54, valued at $166.2k
07/29/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy